Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis

Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior

(2015) M. S. Shiels et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection

(2015) Daniel C. Beachler et al.   JNCI-Journal of the National Cancer Institute

A Longitudinal Study of Human Papillomavirus 16 L1, E6, and E7 Seropositivity and Oral Human Papillomavirus 16 Infection

(2015) Daniel C. Beachler et al.   SEXUALLY TRANSMITTED DISEASES

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection

(2015) Daniel C. Beachler et al.   JNCI-Journal of the National Cancer Institute

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus

(2014) Hilary A Robbins et al.   BMC INFECTIOUS DISEASES

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

(2014) Laia Alemany et al.   INTERNATIONAL JOURNAL OF CANCER

No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM

(2014) Sofie H. Mooij et al.   JOURNAL OF INFECTION

Naturally Acquired Immunity Against Human Papillomavirus (HPV): Why It Matters in the HPV Vaccine Era

(2014) S. Franceschi et al.   JOURNAL OF INFECTIOUS DISEASES

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

(2014) Xavier Castellsagué et al.   JOURNAL OF INFECTIOUS DISEASES

Seroprevalence of 8 Oncogenic Human Papillomavirus Genotypes and Acquired Immunity Against Reinfection

(2014) L. Wilson et al.   JOURNAL OF INFECTIOUS DISEASES

Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States

(2013) Jane J. Kim   ANNALS OF INTERNAL MEDICINE

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

(2013) M. Safaeian et al.   Cancer Prevention Research

Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women

(2013) Yan Tong et al.   JOURNAL OF MEDICAL VIROLOGY

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays

(2013) Shih-Wen Lin et al.   PLoS One

Understanding and learning from the success of prophylactic human papillomavirus vaccines

(2012) John T. Schiller et al.   NATURE REVIEWS MICROBIOLOGY

Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men

(2011) B. Lu et al.   CANCER RESEARCH

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

(2011) A. Szarewski et al.   INTERNATIONAL JOURNAL OF CANCER

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3

(2011) Ana Cecilia Rodríguez et al.   INTERNATIONAL JOURNAL OF CANCER

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

(2011) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

A Competitive Serological Assay Shows Naturally Acquired Immunity to Human Papillomavirus Infections in the Guanacaste Natural History Study

(2011) Nicolas Wentzensen et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006

(2011) Susan Hariri et al.   JOURNAL OF INFECTIOUS DISEASES

Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study

(2011) Anna R Giuliano et al.   LANCET

Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure

(2011) Sarah E. Coseo et al.   SEXUALLY TRANSMITTED DISEASES

Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of Subsequent Infection in Men

(2010) B. Lu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

(2010) M. Safaeian et al.   JNCI-Journal of the National Cancer Institute

Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types

(2009) Rolando Herrero   JOURNAL OF INFECTIOUS DISEASES

Prevalence and Incidence of HPV Genital Infection in Women

(2009) Christine Velicer et al.   SEXUALLY TRANSMITTED DISEASES

Persistent Antibodies to HPV Virus-Like Particles Following Natural Infection Are Protective Against Subsequent Cervicovaginal Infection with Related and Unrelated HPV

(2009) Zainab A. Malik et al.   VIRAL IMMUNOLOGY

Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner

(2008) Rachel L. Winer et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

(2008) F. Xavier Bosch et al.   VACCINE